Mingfeng Zhao

Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma

Yaqing Cao, Wenyi Lu, Rui Sun et al. · Frontiers in Oncology · 2019 · 152 citations · Full text

Chimeric Antigen Receptor, Lymphoid Neoplasia, Cell Therapy +15

<p>Metagenomic Next-Generation Sequencing versus Traditional Pathogen Detection in the Diagnosis of Peripheral Pulmonary Infectious Lesions</p>

Jie Huang, Erlie Jiang, Donglin Yang et al. · Infection and Drug Resistance · 2020 · 150 citations · Full text

ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice

Xiao Chai, Deguan Li, Xiaoli Cao et al. · Scientific Reports · 2015 · 137 citations · Full text

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Yuekun Qi, Mingfeng Zhao, Yongxian Hu et al. · Blood · 2022 · 88 citations · Full text

Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells<i>in vitro</i>and suppresses hematopoiesis in iron overload patients

Wenyi Lu, Mingfeng Zhao, Sajin Rajbhandary et al. · European Journal Of Haematology · 2013 · 86 citations · Full text